Autism as early expression of catatonia

Medical Science Monitor

Volumn 10, Issue 3, 2004, Pages

  Dhossche, Dirk M ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Autism; Catatonia; Children and adolescents; Gamma aminobutyric acid (GABA); Pervasive developmental disorders; Psychotic disorders

Indexed keywords

CLOZAPINE; LORAZEPAM; NEUROLEPTIC AGENT;

ADOLESCENT; AUTISM; CASE REPORT; CATATONIA; CEREBELLUM; CHROMOSOME 15; DISEASE ASSOCIATION; DISEASE COURSE; GABAERGIC TRANSMISSION; HORMONE ACTION; HUMAN; MALE; NEUROIMAGING; OBSESSIVE COMPULSIVE DISORDER; ONSET AGE; PHENOMENOLOGY; REVIEW; TREATMENT FAILURE; TREATMENT OUTCOME;

ADOLESCENT; AGE OF ONSET; AUTISTIC DISORDER; CATATONIA; CEREBELLUM; CHILD; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; PRADER-WILLI SYNDROME; PSYCHOTIC DISORDERS;

EID: 1542721019     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (91)

1. th ed.). Washington, D.C.: American Psychiatric Association, 1994
2. Wing L, Attwood A: Syndromes of autism and atypical development. In: Cohen D, Donnellan A, (eds.) Handbook of autism and pervasive developmental disorders. New York: Wiley-Interscience, 1987; 3-19
3. Rapin I: Autism. N Engl J Med, 1997; 337: 97-104
4. Amir R, van den Veyver I, Wan M et al: Rett syndrome is caused by mutations in X-linked MECP2 encoding methyl-CpG-binding protein 2. Nat Genet, 1999; 23: 185-88
5. Kahlbaum K: Die Katatonie oder das Spannungsirresein. Berlin: Verlag August Hirshwald, 1874
6. Morrison J: Catatonia: retarded and excited types. Arch Gen Psychiatry, 1973; 28: 39-41
7. Abrams R, Taylor M: Catatonia: a prospective clinical study. Arch Gen Psychiatry, 1976; 33: 579-81
8. GelenbÏerg A: The catatonic syndrome. Lancet, 1976; 1: 1339-41
9. Bräunig P, Krüger S, Shugar G: Prevalence and clinical significance of catatonic symptoms in mania. Compr Psychiatry, 1998; 39: 35-46
10. Fink M, Taylor M: Catatonia. A clinician's guide to diagnosis and treatment. Cambridge: University Press, 2003
11. Dhossche D, Bouman N: Catatonia in children and adolescents (letter). J Am Acad Child Adolesc Psychiatry, 1997; 36: 870-71
12. Thakur A, Jagadheesan K, Dutta S, Sinha V: Incidence of catatonia in children and adolescents in a pediatric psychiatric clinic. Aust N Z J Psychiatry, 2003; 37: 200-3
13. Takaoka K, Takaoka T: Catatonia in childhood and adolescence. Psychiatry Clin Neurosci, 2003; 57: 129-37
14. Bemporad J, Bunton H: Catatonic episodes in childhood. Intl J Child Psychotherapy, 1972; 1: 19-44
15. Green W, Padron-Gayol M, Hardesty A, Bassiri M: Schizophrenia with childhood onset: a phenomenological study of 38 cases. J Am Acad Child Adolesc Psychiatry, 1992; 31: 968-76
16. Mahendra B: Where have all the catatonics gone? (Editorial). Psychol Med, 1981; 11: 669-71
17. Rosebush P, Hildebrand A, Furlong B, Mazurek M: Catatonic syndrome in a general psychiatric population: frequency, clinical presentation, and response to lorazepam. J Clin Psychiatry, 1990; 51: 357-62
18. Turner T: Schizophrenia and mental handicap: a historical review, with implications for further research. Psychol Med, 1989; 19: 301-14
19. Rutter M: Childhood schizophrenia reconsidered. J Autism Child Schizophr, 1972; 2: 315-37
20. DeLong R: Children with autistic spectrum disorder and a family history of affective disorder. Dev Med Child Neurol, 1994; 36: 674-88
21. DeLong R, Nohria C: Psychiatric family history and neurological disease in autistic spectrum disorders. Dev Med Child Neurol, 1994; 36: 441-48
22. Volkmar F, Cohen D: Comorbid association of autism and schizophrenia. Am J Psychiatry, 1991; 148: 1705-7
23. Pfuhlmann B, Franzek E, Stöber G et al: On interrater reliability for Leonhard's classification of endogenous psychoses. Psychopathology, 1997; 30: 100-50
24. Beckmann H, Franzek E, Stöber G: Genetic heterogeneity in catatonic schizophrenia: a family study. Am J Med Genet (Neuropsychiatr Genet), 1996; 67: 289-300
25. Stöber G, Saar K, Ruschendorf F et al: Splitting schizophrenia: periodic catatonia susceptibility locus on chromosome 15q15. Am J Hum Genet, 2000; 67: 1201-7
26. Wing L, Shah A: Catatonia in autistic spectrum disorders. Br J Psychiatry, 2000; 176: 357-62
27. Realmuto G, August G: Catatonia in autistic disorder: a sign of comorbidity or variable expression. J Autism Dev Disord, 1991; 21: 517-28
28. Dhossche D: Catatonia in Autistic Disorders (brief report). J Autism Dev Disord, 1998; 28: 329-31
29. Zaw F, Bates G, Murali V, Bentham P: Catatonia, autism, and ECT. Dev Med Child Neurol, 1999; 41: 843-45
30. Taylor M, Fink M: Catatonia in psychiatric classification: a home of its own. Am J Psychiatry, 2003; 160: 1-9
31. Leonhard K: The classification of endogenous psychoses. In: Robins E, (ed.) New York: Irvington Publications, 1979
32. Neumärker K-J: Leonhard and the classification of psychomotor psychoses in childhood and adolescence. Psychopathology, 1990; 23: 243-52
33. Stöber G, Haubitz I, Franzek E, Beckmann H: Parent-of origin effect and evidence for differential transmission in periodic catatonia. Psychiatric Genet, 1998; 8: 213-19
34. Stöber G, Seelow D, Ruschendorf F et al: Periodic catatonia: confirmation of linkage to chromosome 15 and further evidence for genetic heterogeneity. Hum Genet, 2002; 111: 323-30
35. Petty L, Ornitz E, Michelman J, Zimmerman E: Autistic children who become schizophrenic. Arch Gen Psychiatry, 1984; 41: 129-35
36. Kurita H: Delusional disorder in a male adolescent with high-functioning PDDNOS. J Autism Dev Disord, 1999; 29: 419-23
37. Battegay R, Cotar B, Fleischauer J, Rauchfleisch U: Results and side effects of treatment with clozapine. Compr Psychiatry, 1977; 18: 423-28
38. Ungvari G, Leung C, Wong M, Lau J: Benzodiazepines in the treatment of the catatonic syndrome. Acta Psychiatr Scand, 1994; 89: 285-88
39. Bush G, Fink M, Petrides G et al: Catatonia. II. Treatment with lorazepani and electroconvulsive therapy. Acta Psychiatr Scand, 1996; 93: 137-43
40. Clarke D, Littlejohns C, Corbett J, Joseph S: Pervasive developmental disorders and psychoses in adult life. Br J Psychiatry, 1989; 155: 692-99
41. Brasić J, Zagzag D, Kowalik S et al: Progressive catatonia. Psychol Rep, 1999; 84: 239-46
42. Kurita H, Kita M, Miyake Y: A comparative study of development and symptoms among disintegrative psychosis and infantile autism with and without speech loss. J Autism Dev Disord, 1992; 22: 175-88
43. Dhossche D, Bouman N: Catatonia in an adolescent with Prader-Willi Syndrome. Ann Clin Psychiatry, 1997; 4: 247-53
44. Burd L, Vesely B, Martsolf J, Kerbeshian J: Prevalence study of Prader-Willi syndrome in North Dakota. Am J Med Genet, 1990; 37: 97-99
45. Smith A, Egan J, Ridley G et al: Birth prevalence of Prader-Willi Syndrome in Australia. Arch Dis Child, 2003; 88: 263-64
46. Holm V, Cassidy S, Butler M et al: Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics, 1993; 2: 398-402
47. Wigren M, Hansen S: Rituals and compulsivity in Prader-Willi syndrome: profile and stability. J Intellect Disabil Res, 2003; 47: 428-38
48. Clarke D: Prader-Willi syndrome and psychoses. Br J Psychiatry, 1993; 163: 680-84
49. Boer H, Holland A, Whittington J et al: Psychotic illness in people with Prader-Willi syndrome due to chromosome 15 maternal uniparental disomy. Lancet, 2002; 12: 135-36
50. Nyhan W: Behavior in the Lesch-Nyhan syndrome. J Autism Child Schizophr, 1976; 6: 235-52
51. Woodage T, Deng Z, Prasad M et al: A variety of genetic mechanisms are associated with the Prader-Willi Syndrome. Am J Med Genet (Neuropsychiatr Genet), 1994; 54: 219-26
52. Angelman H: 'Puppet' children. A report of three cases. Dev Med Child Neurol, 1965; 7: 681-88
53. Schmickel R: Contiguous gene syndromes: a component of recognizable syndromes. J Pediatr, 1986; 109: 231-41
54. Lauritsen M, Mors O, Mortensen P, Ewald H: Infantile autism and associated autosomal chromosome abnormalities: a register-based study and a literature survey. J Child Psychol Psychiatry, 1999; 40: 335-45
55. Cook E, Lindgren V, Levental B et al: Autism or atypical autism in maternally but not paternally derived proximal 15q duplication. Am J Hum Genet, 1997; 60: 928-34
56. Borgatti R, Piccinelli P, Passoni D et al: Relationship between clinical and genetic features in 'inverted duplicated chromosome 15′ patients. Pediatr Neurol, 2001; 24: 111-16
57. Northoff G, Steinke R, Czcervenka C et al: Decreased density of GABA-A receptors in the left sensorimotor cortex in akinetic catatonia: investigation of in vivo benzodiazepine receptor binding. J Neurol Neurosurg Psychiatry, 1999; 67: 445-50
58. Fricchione G, Cassem N, Hooberman D, Hobson D: Intravenous lorazepam in neuroleptic-induced catatonia. J Clin Psychopharmacol, 1983; 3: 338-42
59. Green A: Changes in gamma-aminobutyric acid biochemistry and seizure threshold. Ann N Y Acad Sc, 1986; 462: 105-19
60. Sanacora G, Mason G, Rothman D et al: Increased cortical GABA concentrations in depressed patients receiving ECT. Am J Psychiatry, 2003; 160: 577-79
61. Rolf L, Haarmann F, Grotemeyer K-N, Kehrer H: Serotonin and amino acid contents in platelets of autistic children. Acta Psychiatr Scand, 1993; 87: 312-16
62. Cohen B: Elevated levels of plasma and urine gamma-aminobutyric acid: a case study of an autistic child (letter). Autism, 1999; 3: 437-40
63. Dhossche D, Applegate H, Abraham A et al: Elevated plasma GABA levels in autistic youngsters: stimulus for a GABA hypothesis of autism. Med Sci Monit, 2002: PR1-6
64. Blatt G, Fitzgerald C, Guptill J et al: Density and distribution of hippocampal neurotransmitter receptors in autism: an autoradiographic study. J Autism Dev Disord, 2001; 31: 537-43
65. Soghomonian J, Martin D: Two isoforms of glutamate decarboxylase: why? Trends Pharmacol Sci, 1998; 19: 500-5
66. Fatemi S, Halt A, Stary J et al: Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices. Biol Psychiatry, 2002; 52: 805-10
67. Roberts E: Adventures with GABA. Fifty years on. In: Martin D, Olsen R, (eds.) GABA in the nervous system. The view at fifty years. Philadephia, PA: Lippincott Williams & Wilkins, 2000; 1-24
68. Varju P, Katarova Z, Madarasz E, Szabo G: GABA signaling during development: new data and old questions. Cell Tissue Res, 2001; 305: 239-46
69. Herlenius E, Lagercrantz H: Neurotransmitters and neuromodulators during early human development. Early Hum Dev, 2001; 65: 21-37
70. Christie S, Miralles C, De Blas A: GABAergic innervation organizes synaptic and extrasynaptic GABAA receptor clustering in cultured hippocampal neurons. J Neurosci, 2002; 22: 684-97
71. Courchesne E, Yeung-Courchesne R, Press G et al: Hypoplasia of cerebellar vermis lobules VI and VII in autism. N Engl J Med, 1988; 318: 1349-54
72. Courchesne E, Karns C, Davis H et al: Unusual brain growth patterns in early life in patients with autistic disorder: an MRI study. Neurology, 2001; 24: 245-54
73. Mitushima D, Hei D, Terasawa E: Gamma-aminobutyric acid is an inhibitory neurotransmitter restricting the release of luteinizing hormone-releasing hormone before the onset of puberty. Proc Natl Acad Sci USA, 1994; 91: 395-99
74. Genazzani A, Bernardi F, Monteleone P et al: Neuropeptides, neurotransmitters, neurosteroids, and the onset of puberty. Ann NY Acad Sci, 2000; 9000: 1-9
75. Deykin E, MacMahon B: The incidence of seizures among children with autistic symptoms. Am J Psychiatry, 1979; 136: 1310-12
76. Gillberg C: The treatment of epilepsy in autism. J Autism Dev Disord, 1991; 21: 61-77
77. Gillberg C, Schaumann H: Infantile autism and puberty. J Autism Dev Disord, 1981; 11: 365-71
78. Gillberg C: Outcome in autism and autistic-like symptoms. J Am Acad Child Adolesc Psychiatry, 1991; 30: 375-82
79. Petroff O, Rothman D, Behar K, Mattson R: Low brain GABA level is associated with poor seizure control. Ann Neurology, 1996; 40: 908-11
80. Ebert M, Schmidt D, Thompson T, Butler M: Elevated gammaaminobutyric acid (GABA) levels in individuals with either PraderWilli Syndrome or Angelman Syndrome. J Neuropsychiatry Clin Neurosci, 1997; 9: 75-80
81. Odano I, Anezaki T, Ohkubo M et al: Decrease in benzodiazepine receptor binding in a patient with Angelman syndrome detected by iodine-123 iomazenil and single-photon emission tomography. Eur J Nucl Med, 1996; 23: 598-604
82. DeLorey T, Handforth A, Anagnostaras S et al: Mice lacking the beta3 subunit of the GABAA receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome. J Neurosci, 1998; 18: 8505-14
83. Shao Y, Cuccaro M, Hauser E et al: Fine mapping of Autistic Disorder to chromosome 15q11-q13 by use of phenotypic subtypes. Am J Hum Genet, 2003; 72: 539-48
84. Nurmi E, Dowd M, Tadevosyan-Leyfer O et al: Exploratory subsetting of autism families based on savant skills improves evidence of genetic linkage to 15q11-13. J Am Acad Child Adolesc Psychiatry, 2003; 42: 856-63
85. Joseph A, Anderson W, O'Leary D: Brainstem and vermis atrophy in catatonia. Am J Psychiatry, 1985; 142: 352-54
86. Wilcox J: Cerebellar atrophy and catatonia. Biological Psychiatry, 1991; 29: 733-34
87. Kaufmann W, Cooper K, Mostofsky S et al: Specificity of cerebellar vermian abnormalities in autism: a quantitative magnetic resonance imaging study. J Child Neurology, 2003; 18: 463-70
88. Allen G, Courchesne E: Differential effects of developmental cerebellar abnormality on cognitive and motor functions in the cerebellum: an fMRI study of autism. Am J Psychiatry, 2003; 160: 262-73
89. Levishon L, Cronin-Golomb A, Schmahmann J: Neuropsychological consequences of cerebellar tumour resection in children. Cerebellar cognitive affective syndrome in a paediatric population. Brain, 2000; 123: 1041-50
90. Kern J: Purkinje cell vulnerability and autism: a possible etiological connection. Brain Dev, 2003; 25: 377-82
91. Kolvin I: Studies in the childhood psychoses. I. Diagnostic criteria and classification. Br J Psychiatry, 1971; 118: 381-84